In agreement with previous studies on different autophagy related-genes, our work demonstrated for the first time that the GABARAP family genes, and particularly GABARAPL1, are regulated by epigenetic modifications in BC and that epigenetic inhibitors might be used in combination with classical anti-chemotherapeutive drugs for futures anti-cancer therapies. This evidence concerns the gene GABARAPL1 and cancer.